Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20336787rdf:typepubmed:Citationlld:pubmed
pubmed-article:20336787lifeskim:mentionsumls-concept:C0281361lld:lifeskim
pubmed-article:20336787lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:20336787lifeskim:mentionsumls-concept:C0728940lld:lifeskim
pubmed-article:20336787lifeskim:mentionsumls-concept:C0677850lld:lifeskim
pubmed-article:20336787lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:20336787pubmed:issue12lld:pubmed
pubmed-article:20336787pubmed:dateCreated2010-6-21lld:pubmed
pubmed-article:20336787pubmed:abstractTextThe use of adjuvant chemoradiation for pancreatic adenocarcinoma (PAC) is accepted in North America, but there is a paucity of data to support this practice. The relation between adjuvant therapy and survival was assessed in a population-based cohort of patients with PAC.lld:pubmed
pubmed-article:20336787pubmed:languageenglld:pubmed
pubmed-article:20336787pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20336787pubmed:citationSubsetAIMlld:pubmed
pubmed-article:20336787pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20336787pubmed:statusMEDLINElld:pubmed
pubmed-article:20336787pubmed:monthJunlld:pubmed
pubmed-article:20336787pubmed:issn0008-543Xlld:pubmed
pubmed-article:20336787pubmed:authorpubmed-author:BillingsleyKe...lld:pubmed
pubmed-article:20336787pubmed:authorpubmed-author:MoriMotomiMlld:pubmed
pubmed-article:20336787pubmed:authorpubmed-author:AustinDonald...lld:pubmed
pubmed-article:20336787pubmed:authorpubmed-author:SheppardBrett...lld:pubmed
pubmed-article:20336787pubmed:authorpubmed-author:MayoSkye CSClld:pubmed
pubmed-article:20336787pubmed:authorpubmed-author:ShipleyDonald...lld:pubmed
pubmed-article:20336787pubmed:issnTypePrintlld:pubmed
pubmed-article:20336787pubmed:day15lld:pubmed
pubmed-article:20336787pubmed:volume116lld:pubmed
pubmed-article:20336787pubmed:ownerNLMlld:pubmed
pubmed-article:20336787pubmed:authorsCompleteYlld:pubmed
pubmed-article:20336787pubmed:pagination2932-40lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:meshHeadingpubmed-meshheading:20336787...lld:pubmed
pubmed-article:20336787pubmed:year2010lld:pubmed
pubmed-article:20336787pubmed:articleTitleAdjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.lld:pubmed
pubmed-article:20336787pubmed:affiliationDepartment of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.lld:pubmed
pubmed-article:20336787pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20336787pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed